180 Life Sciences Corp. Files 8-K/A Amendment
Ticker: FRMM · Form: 8-K/A · Filed: Apr 1, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K/A |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, filing-update
Related Tickers: ATNF
TL;DR
180 Life Sciences amended its 8-K filing from Dec 27, 2024, updating key corporate events and disclosures.
AI Summary
180 Life Sciences Corp. filed an amendment (8-K/A) on April 1, 2025, regarding events that occurred on December 27, 2024. The filing addresses material modifications to security holder rights, changes in control, director and officer appointments, matters submitted to a vote, and other events, including financial statements and exhibits. This amendment supersedes previous filings related to these items.
Why It Matters
This amendment clarifies and updates previously reported information concerning significant corporate events, providing a more complete picture for investors regarding the company's structure and governance.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings can indicate evolving corporate situations, requiring investors to carefully review updated information for potential risks or changes in strategy.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former Company Name
- 2024-12-27 (date) — Date of events reported
- 20250401 (date) — Filing Date
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose is to amend and supplement the company's previous 8-K filing dated December 27, 2024, to provide updated or additional information on various corporate events.
What specific items are being amended or supplemented by this filing?
This filing addresses material modifications to rights of security holders, changes in control, departure/election of directors and officers, compensatory arrangements, submission of matters to a vote, and other events, including financial statements and exhibits.
When did the events reported in the original 8-K filing occur?
The events reported in the original 8-K filing occurred on December 27, 2024.
What was 180 Life Sciences Corp.'s former company name?
180 Life Sciences Corp.'s former company name was KBL Merger Corp. IV.
What is the SIC code for 180 Life Sciences Corp.?
The Standard Industrial Classification (SIC) code for 180 Life Sciences Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on April 1, 2025 regarding 180 Life Sciences Corp. (FRMM).